| Literature DB >> 34925353 |
Huma Shehwana1, Sadaf Ijaz2, Abeera Fatima2, Shelley Walton3, Zafar Iqbal Sheikh4, Waseem Haider5, Shumaila Naz1.
Abstract
Scabies, a human skin infestation caused by the ectoparasitic mite Sarcoptes scabiei var. hominis, affects more than 200 million people globally. The prevailing knowledge of the disease process and host immune response mechanisms is limited. A better understanding of the host-parasite relationship is essential for the identification of novel vaccine and drug targets. Here we aimed to interrogate the transcriptomic profiles of mite-infested human skin biopsies with clinical manifestations of ordinary scabies subjects ("OS"; n = 05) and subjects naive to scabies ("control"; n = 03) using RNASeq data analysis. A combined clustering, network, and pathway mapping approach enabled us to identify key signaling events in the host immune and pro-inflammatory responses to S. scabiei infestation. The clustering patterns showed various differentially expressed genes including inflammatory responses and innate immunity genes (DEFB4A, IL-19, CXCL8, CSF3, SERPINB4, S100A7A, HRNR) and notably upregulation of the JAK-STAT pathway in scabies-infested samples. Mite-infested human skin biopsies (GSE178563) were compared with an ex-vivo porcine infested model (E-MTAB-6433) and human skin equivalents (GSE48459). Marked enrichment of immune response pathways (JAK-STAT signaling, IL-4 and IL-13 pathway, and Toll receptor cascade), chemokine ligands and receptors (CCL17, CCL18, CCL3L1, CCL3L3, CCR7), and cytokines (IL-13 and IL-20) were observed. Additionally, genes known for their role in psoriasis and atopic dermatitis were upregulated, e.g., IL-19. The detailed transcriptomic profile has provided an insight into molecular functions, biological processes, and immunological responses and increased our understanding about transcriptomic regulation of scabies in human.Entities:
Keywords: JAK-STAT pathways; RNA-seq data analysis; Sarcoptes scabiei. var. hominis; differentially expressed genes; inflammatory responses; scabies
Mesh:
Year: 2021 PMID: 34925353 PMCID: PMC8671885 DOI: 10.3389/fimmu.2021.778840
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 7.561
Figure 1Workflow of the project.
Figure 2Transcriptome profile of human skin biopsies infested with mite (S. scabiei var. hominis) (A) PCA plot using raw RNA-seq expression counts of eight samples (three control and five OS samples). (B) Volcano plot of differential expression profile of all genes with upregulated (p < 0.05 and logFC>2) and downregulated (p < 0.05 and logFC < 2) genes shown in red and blue respectively. (C) NGCHM plot of top 1,000 differentially expressed genes using unsupervised hierarchical clustering in both directions (rows and columns). Covariates include age, gender, and duration of exposure and diseased group (With lesion represents OS samples, and No lesion represents control samples).
Top 20 upregulated and downregulated genes in mite-infested human skin biopsies (n=5) with respect to control samples (n = 3).
| Ensembl Gene ID | HGNC Symbol | logFC | logCPM | PValue | FDR | |
|---|---|---|---|---|---|---|
|
| ENSG00000171711 | DEFB4A | 12.76 | 3.96 | 1.71E-15 | 2.34E-11 |
| ENSG00000142224 | IL19 | 10.76 | 6.10 | 4.04E-16 | 8.35E-12 | |
| ENSG00000206073 | SERPINB4 | 10.58 | 6.85 | 1.93E-16 | 7.98E-12 | |
| ENSG00000171403 | KRT9 | 9.62 | 11.71 | 2.27E-15 | 2.34E-11 | |
| ENSG00000135625 | EGR4 | 9.58 | 0.81 | 8.08E-10 | 1.59E-06 | |
| ENSG00000166670 | MMP10 | 9.45 | 0.68 | 1.37E-09 | 2.37E-06 | |
| ENSG00000108342 | CSF3 | 9.26 | 0.50 | 2.93E-09 | 4.02E-06 | |
| ENSG00000170465 | KRT6C | 9.19 | 9.90 | 1.42E-14 | 1.17E-10 | |
| ENSG00000184330 | S100A7A | 9.16 | 4.89 | 1.75E-13 | 1.20E-09 | |
| ENSG00000204909 | SPINK9 | 8.63 | 1.51 | 4.55E-11 | 1.25E-07 | |
| ENSG00000169429 | CXCL8 | 8.59 | 4.67 | 4.33E-13 | 2.23E-09 | |
| ENSG00000171450 | CDK5R2 | 8.44 | −0.28 | 7.48E-08 | 5.33E-05 | |
| ENSG00000163209 | SPRR3 | 8.40 | −0.31 | 8.86E-08 | 5.90E-05 | |
| ENSG00000197915 | HRNR | 8.32 | 6.41 | 6.73E-13 | 3.09E-09 | |
| ENSG00000258397 | BCAR1P1 | 8.26 | −0.46 | 1.52E-07 | 8.71E-05 | |
| ENSG00000185962 | LCE3A | 7.97 | 5.19 | 5.77E-12 | 1.83E-08 | |
| ENSG00000215151 | ABCD1P2 | 7.96 | −0.74 | 4.88E-07 | 2.26E-04 | |
| ENSG00000241794 | SPRR2A | 7.94 | 6.49 | 3.72E-12 | 1.28E-08 | |
| ENSG00000259098 | 7.92 | −0.77 | 5.69E-07 | 2.55E-04 | ||
| ENSG00000226807 | MROH5 | 7.65 | −1.01 | 1.57E-06 | 5.51E-04 | |
|
| ENSG00000211640 | IGLV6-57 | −7.29 | −1.86 | 1.57E-08 | 1.47E-05 |
| ENSG00000270550 | IGHV3-30 | −7.25 | −1.89 | 1.83E-08 | 1.64E-05 | |
| ENSG00000211637 | IGLV4-69 | −7.02 | −2.07 | 6.86E-08 | 5.06E-05 | |
| ENSG00000273018 | FAM106A | −6.98 | −2.10 | 8.20E-08 | 5.64E-05 | |
| ENSG00000240708 | LINC02030 | −6.91 | −2.15 | 1.43E-07 | 8.55E-05 | |
| ENSG00000251027 | LINC01950 | −6.76 | −2.27 | 3.16E-07 | 1.61E-04 | |
| ENSG00000253692 | IGHEP1 | −6.69 | −1.14 | 3.02E-09 | 4.02E-06 | |
| ENSG00000135226 | UGT2B28 | −6.61 | −2.36 | 7.48E-07 | 3.12E-04 | |
| ENSG00000229453 | SPINK8 | −6.54 | −2.42 | 9.39E-07 | 3.66E-04 | |
| ENSG00000235584 | −6.39 | −2.52 | 2.47E-06 | 7.96E-04 | ||
| ENSG00000187481 | HSD3BP1 | −6.38 | −2.53 | 2.47E-06 | 7.96E-04 | |
| ENSG00000205456 | TP53TG3D | −6.29 | −2.59 | 4.16E-06 | 1.18E-03 | |
| ENSG00000223342 | −6.24 | −2.64 | 4.16E-06 | 1.18E-03 | ||
| ENSG00000276405 | TRBV13 | −6.15 | −2.69 | 7.21E-06 | 1.86E-03 | |
| ENSG00000172461 | FUT9 | −6.12 | −1.55 | 8.07E-08 | 5.64E-05 | |
| ENSG00000124935 | SCGB1D2 | −6.10 | 6.65 | 3.68E-13 | 2.17E-09 | |
| ENSG00000277010 | −6.10 | −1.01 | 5.14E-09 | 6.06E-06 | ||
| ENSG00000188984 | AADACL3 | −6.09 | 1.77 | 2.90E-12 | 1.09E-08 | |
| ENSG00000152591 | DSPP | −6.08 | −2.71 | 9.61E-06 | 2.28E-03 | |
| ENSG00000162877 | PM20D1 | −6.02 | 3.05 | 1.44E-12 | 5.92E-09 |
Figure 3Pathway enrichment analysis of differentially expressed genes (GSE178563). Significantly (A) upregulated and (B) downregulated pathways (FDR<0.05) enriched in differentially expressed genes using Gene Ontology biological processes, molecular function, and KEGG database by DAVID web tool.
Figure 4GSEA of raw counts data using Gene Ontology-Biological processes. Pathways upregulated in OS diseased samples are shown in red, while pathways enriched in control samples are shown in blue. Node size indicates size of that gene set, and edge width indicates the similarity coefficient between two gene sets.
Figure 5Bar plot of itch-associated genes of GSE178563 (mite-infested human skin biopsies).
Number of differentially expressed genes in mite-infested porcine and human samples.
| Porcine comparison groups | Time series | Number of DE genes in mite-infested porcine groups (E-MTAB-6433) | Number of human orthologs (Ensembl Biomart) | % of retrieved human ortholog w.r.t. number of DEGs in porcine group | DEGs in mite-infested human skin biopsies (GSE178563; p<0.05) | % of DEGS in human samples w.r.t. total number of retrieved orthologs |
|---|---|---|---|---|---|---|
|
| Week 0 | 1,552 | 1,290 | 83.12% | 153 | 11.86% |
| Week 1 | 1,202 | 1,015 | 84.44% | 114 | 11.23% | |
| Week 2 | 1,272 | 1,067 | 83.88% | 105 | 9.84% | |
| Week 4 | 367 | 306 | 83.38% | 45 | 14.71% | |
| Week 8 | 1,006 | 842 | 83.70% | 98 | 11.64% | |
|
| Week 0 | 344 | 287 | 83.43% | 34 | 11.85% |
| Week 1 | 952 | 797 | 83.72% | 75 | 9.41% | |
| Week 2 | 1,955 | 1,640 | 83.89% | 181 | 11.04% | |
| Week 4 | 758 | 622 | 82.06% | 84 | 13.50% | |
| Week 8 | 1,573 | 1,322 | 84.04% | 154 | 11.65% | |
|
| Week 0 | 1,297 | 1,072 | 82.65% | 572 | 53.36% |
| Week 1 | 1,305 | 1,074 | 82.30% | 108 | 10.06% | |
| Week 2 | 1,651 | 1,366 | 82.74% | 148 | 10.83% | |
| Week 4 | 261 | 217 | 83.14% | 22 | 10.14% | |
| Week 8 | 1,292 | 1,081 | 83.67% | 149 | 13.78% |
Figure 6Comparative analysis of GSE178563 (mite-infested human skin biopsies) with E-MTAB-6433 (mite-infested pig biopsies). (A) Association between significantly modulated differential expression profiles of human infested skin biopsies with each time point (Week 0,1,2,4,8) of porcine infested groups. Association statistics (contingency table along with odds ratio and fisher’s exact p-value) and correlation plots of significant porcine groups, i.e (1)., CS vs. C (B, C) and (2) CS vs. OS (D, E). Combined Venn diagram of all significantly associated groups identified in (F, G) (Week 8 CS vs. C and Week 8 CS vs. OS mite-infested human samples vs. control).
KEGG pathway enrichment of common genes in mite-infested human (Scabies vs. control) and porcine groups (Week 8; CS vs. OS and CS vs. C).
| Comparison Group | Disease condition in Human and Pigs | Gene Set Name | # Genes in Gene Set (K) | Description | # Genes in Overlap (k) | k/K | FDR q-value |
|---|---|---|---|---|---|---|---|
|
| Commonly Upregulated | GOBP_RESPONSE_TO_ENDOGENOUS_STIMULUS | 1624 | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus arising within the organism. [GOC:sm] | 9 | 5.50E-03 | 1.25E-03 |
| GOBP_CHEMICAL_HOMEOSTASIS | 1187 | Any biological process involved in the maintenance of an internal steady state of a chemical. [GOC:isa_complete] | 8 | 6.70E-03 | 1.25E-03 | ||
| KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION | 265 | Cytokine-cytokine receptor interaction | 9 | 3.40E-02 | 3.79E-09 | ||
| REACTOME_SIGNALING_BY_INTERLEUKINS | 463 | Signaling by Interleukins | 9 | 1.94E-02 | 2.70E-07 | ||
| REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM | 719 | Cytokine Signaling in Immune system | 10 | 1.39E-02 | 4.12E-07 | ||
| REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES | 58 | Chemokine receptors bind chemokines | 5 | 8.62E-02 | 9.73E-07 | ||
| KEGG_CHEMOKINE_SIGNALING_PATHWAY | 189 | Chemokine signaling pathway | 6 | 3.17E-02 | 7.23E-06 | ||
| REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING | 111 | Interleukin-4 and Interleukin-13 signaling | 5 | 4.50E-02 | 1.75E-05 | ||
| REACTOME_INNATE_IMMUNE_SYSTEM | 1117 | Innate Immune System | 9 | 8.10E-03 | 1.48E-04 | ||
| REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 198 | Peptide ligand-binding receptors | 5 | 2.53E-02 | 2.33E-04 | ||
| REACTOME_NEUTROPHIL_DEGRANULATION | 479 | Neutrophil degranulation | 6 | 1.25E-02 | 9.23E-04 | ||
| REACTOME_INTERLEUKIN_10_SIGNALING | 46 | Interleukin-10 signaling | 3 | 6.52E-02 | 1.88E-03 | ||
| Commonly Downregulated | KEGG_PPAR_SIGNALING_PATHWAY | 69 | PPAR signaling pathway | 4 | 5.80E-02 | 1.73E-04 | |
| REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 84 | Transcriptional regulation of white adipocyte differentiation | 3 | 3.57E-02 | 1.74E-02 | ||
| REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 297 | Signaling by Nuclear Receptors | 4 | 1.35E-02 | 1.93E-02 | ||
| Downregulated in Porcine and Upregulated in Humans | No enrichment | ||||||
| Upregulated in Porcine and downregulated in Humans | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | 186 | Transport to the Golgi and subsequent modification | 4 | 2.15E-02 | 1.70E-02 | |
| REACTOME_THYROXINE_BIOSYNTHESIS | 10 | Thyroxine biosynthesis | 2 | 2.00E-01 | 2.01E-02 | ||
| REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_GROWTH_FACTORS_AND_THEIR_RECEPTORS | 15 | TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | 2 | 1.33E-01 | 2.69E-02 | ||
| REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | 305 | Asparagine N-linked glycosylation | 4 | 1.31E-02 | 2.69E-02 | ||
| REACTOME_METABOLISM_OF_AMINE_DERIVED_HORMONES | 18 | Metabolism of amine-derived hormones | 2 | 1.11E-01 | 2.69E-02 | ||
| REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 331 | Class A/1 (Rhodopsin-like receptors) | 4 | 1.21E-02 | 2.69E-02 | ||
| GOBP_ENZYME_LINKED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY | 1072 | Any series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell, where the receptor possesses catalytic activity or is closely associated with an enzyme such as a protein kinase, and ending with regulation of a downstream cellular process, e.g. transcription. [GOC:mah, GOC:signaling, ISBN:0815316194] | 10 | 9.30E-03 | 1.97E-05 | ||
| GOBP_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_SIGNALING_PATHWAY | 737 | A series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell where the receptor possesses tyrosine kinase activity, and ending with regulation of a downstream cellular process, e.g. transcription. [GOC:ceb, GOC:signaling] | 8 | 1.09E-02 | 1.69E-04 | ||
| GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS | 296 | Any process that modulates the rate, frequency, or extent of a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth factor stimulus. [GOC:tb] | 6 | 2.03E-02 | 1.79E-04 | ||
| GOBP_CELL_MIGRATION | 1602 | The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms. [GOC:cjm, GOC:dph, GOC:ems, GOC:pf, Wikipedia:Cell_migration] | 10 | 6.20E-03 | 1.79E-04 | ||
| GOBP_TRANSMEMBRANE_TRANSPORT | 1605 | The process in which a solute is transported across a lipid bilayer, from one side of a membrane to the other. [GOC:dph, GOC:jid] | 10 | 6.20E-03 | 1.79E-04 | ||
| GOMF_MOLECULAR_TRANSDUCER_ACTIVITY | 1489 | A compound molecular function in which an effector function is controlled by one or more regulatory components. [GOC:dos, GOC:pdt] | 9 | 6.00E-03 | 8.69E-04 | ||
| GOBP_LOCOMOTION | 1975 | Self-propelled movement of a cell or organism from one location to another. [GOC:dgh] | 10 | 5.10E-03 | 8.69E-04 | ||
| GOBP_ION_HOMEOSTASIS | 787 | Any process involved in the maintenance of an internal steady state of ions within an organism or cell. [GOC:ai] | 7 | 8.90E-03 | 1.25E-03 | ||
|
| Commonly Upregulated | KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION | 265 | Cytokine-cytokine receptor interaction | 8 | 3.02E-02 | 2.14E-08 |
| REACTOME_SIGNALING_BY_INTERLEUKINS | 463 | Signaling by Interleukins | 7 | 1.51E-02 | 2.83E-05 | ||
| REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM | 719 | Cytokine Signaling in Immune system | 7 | 9.70E-03 | 3.69E-04 | ||
| KEGG_JAK_STAT_SIGNALING_PATHWAY | 155 | Jak-STAT signaling pathway | 4 | 2.58E-02 | 2.07E-03 | ||
| REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES | 58 | Chemokine receptors bind chemokines | 3 | 5.17E-02 | 3.03E-03 | ||
| KEGG_CHEMOKINE_SIGNALING_PATHWAY | 189 | Chemokine signaling pathway | 4 | 2.12E-02 | 3.03E-03 | ||
| REACTOME_THYROXINE_BIOSYNTHESIS | 10 | Thyroxine biosynthesis | 2 | 2.00E-01 | 5.73E-03 | ||
| REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE | 103 | Toll Like Receptor TLR1:TLR2 Cascade | 3 | 2.91E-02 | 1.24E-02 | ||
| REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING | 111 | Interleukin-4 and Interleukin-13 signaling | 3 | 2.70E-02 | 1.24E-02 | ||
| REACTOME_IRAK4_DEFICIENCY_TLR2_4 | 18 | IRAK4 deficiency (TLR2/4) | 2 | 1.11E-01 | 1.24E-02 | ||
| Commonly Downregulated | No enrichment | ||||||
| Downregulated in Porcine and Upregulated in humans | No enrichment | ||||||
|
| Upregulated in Porcine and downregulated in Humans | REACTOME_METABOLISM_OF_AMINE_DERIVED_HORMONES | 18 | Metabolism of amine-derived hormones | 2 | 1.11E-01 | 2.62E-02 |
Figure 7Comparative transcriptomic analysis of GSE178563 (mite-infested human skin biopsies) with GSE48459 (live-mite-infested human skin equivalent group). (A, B) Correlation plot of logFC profiles and association statistics (contingency table and fisher’s exact test) of significantly differentially expressed genes in mite-infested human skin biopsies and in-vitro human skin equivalents. (C, D) Venn diagram of common significantly upregulated and downregulated genes. Significantly enriched pathways in the shared profiles are mentioned.